Noticia

The Lupus Research Alliance is the largest private funder of lupus research, united to free the world of lupus by harnessing the power of science to make a difference for people living with this autoimmune disease. Merging the resources of the former Alliance for Lupus Research, Lupus Research Institute and the S.L.E. Lupus Foundation, the new organization has collectively committed over $173 million for the most innovative lupus research around the globe.

Research Funding Mechanisms:

• Dr. William E. Paul Distinguished Innovator Award (DIA) in Lupus and Autoimmunity: The Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity was created to address the current lack of treatments in development that could arrest or reverse the disease.


• Target Identification in Lupus Grant (TIL) Program: Under our Target Identification in Lupus (TIL) grant program, investigators leverage a two-year, up-to-$400,000 award, to remove the barriers to new treatments and a possible cure. All research funded under the TIL program is based on realizable goals for translation into therapeutic discovery programs — that is, research that can move quickly from the laboratory to the patient’s bedside. 


• Novel Research Grants (Novel): The Novel Research Grant program provides early-stage support with three-year $300,000 grants for high-risk, high-reward, idea-driven, novel research projects relevant to basic, translational or clinical investigation in lupus. Exceptionally creative and innovative, projects advance novel scientific hypotheses in lupus, aim to stimulate investigation of underexplored pathways, and initiate transformative discoveries that can drive the development of safer and more effective treatments.


• Lupus Investigators Network Grants (LuCin): The Lupus Investigators Network (LuCIN) was formed to accelerate the identification and development of new therapies to treat lupus. The goals of LuCIN are to: conduct safe and reliable clinical studies to test drugs already approved for other diseases or new compounds for their potential use as treatments for lupus; facilitate sharing of clinical and biological data to better understand lupus; and enlist patient input and participation in clinical studies. 

More information in the next document: Lupus Research Alliance Grants